GB202206257D0 - Biomarkers of diabetic nephropathy - Google Patents
Biomarkers of diabetic nephropathyInfo
- Publication number
- GB202206257D0 GB202206257D0 GBGB2206257.4A GB202206257A GB202206257D0 GB 202206257 D0 GB202206257 D0 GB 202206257D0 GB 202206257 A GB202206257 A GB 202206257A GB 202206257 D0 GB202206257 D0 GB 202206257D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- biomarkers
- diabetic nephropathy
- nephropathy
- diabetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000007342 Diabetic Nephropathies Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 208000033679 diabetic kidney disease Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2206257.4A GB202206257D0 (en) | 2022-04-29 | 2022-04-29 | Biomarkers of diabetic nephropathy |
| EP23723436.4A EP4515245A1 (en) | 2022-04-29 | 2023-04-26 | Biomarkers of diabetic nephropathy |
| PCT/EP2023/060911 WO2023208993A1 (en) | 2022-04-29 | 2023-04-26 | Biomarkers of diabetic nephropathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2206257.4A GB202206257D0 (en) | 2022-04-29 | 2022-04-29 | Biomarkers of diabetic nephropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202206257D0 true GB202206257D0 (en) | 2022-06-15 |
Family
ID=81943882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2206257.4A Ceased GB202206257D0 (en) | 2022-04-29 | 2022-04-29 | Biomarkers of diabetic nephropathy |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4515245A1 (en) |
| GB (1) | GB202206257D0 (en) |
| WO (1) | WO2023208993A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0874242B2 (en) | 1997-04-21 | 2009-06-03 | Randox Laboratories Ltd. | Device and apparatus for the simultaneous detection of multiple analytes |
| EP2913676A1 (en) * | 2008-11-10 | 2015-09-02 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| DK2406636T3 (en) * | 2008-12-10 | 2019-02-18 | Joslin Diabetes Center Inc | PROCEDURES FOR DIAGNOSTICATION AND PREVENTION OF RENAL DISEASE |
| GB201804648D0 (en) * | 2018-03-22 | 2018-05-09 | Randox Laboratories Ltd | Combination biomarker |
-
2022
- 2022-04-29 GB GBGB2206257.4A patent/GB202206257D0/en not_active Ceased
-
2023
- 2023-04-26 WO PCT/EP2023/060911 patent/WO2023208993A1/en not_active Ceased
- 2023-04-26 EP EP23723436.4A patent/EP4515245A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023208993A1 (en) | 2023-11-02 |
| EP4515245A1 (en) | 2025-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4093513A4 (en) | Uses of biomarkers for improving immunotherapy | |
| PL4070111T3 (en) | Use of cell free nucleosomes as biomarkers | |
| GB202206257D0 (en) | Biomarkers of diabetic nephropathy | |
| ZA202108391B (en) | Biomarkers for predicting progression of intravenous leiomyomatosis | |
| GB202014880D0 (en) | Detection of biomarkers | |
| GB202112831D0 (en) | Biomarker | |
| GB202014190D0 (en) | Biomarkers | |
| EP4083627A4 (en) | Prognostic biomarker of cancer | |
| GB202216420D0 (en) | Biomarkers of pregnancy loss | |
| GB202103951D0 (en) | Biomarkers | |
| GB202107813D0 (en) | Biomarker | |
| GB202015056D0 (en) | Biomarkers | |
| GB202114694D0 (en) | Prediction of fade outages | |
| GB202314954D0 (en) | Biomarkers | |
| GB202216295D0 (en) | Biomarkers | |
| GB202215749D0 (en) | Biomarkers | |
| GB202212826D0 (en) | Biomarkers | |
| GB202307768D0 (en) | Use of cell free nucleosomes as biomarkers | |
| GB202509310D0 (en) | Biomarkers | |
| GB202419126D0 (en) | Biomarkers | |
| GB202418087D0 (en) | Biomarkers | |
| GB202413914D0 (en) | Biomarkers | |
| GB202411373D0 (en) | Biomarkers | |
| GB202409296D0 (en) | Biomarkers | |
| GB202403274D0 (en) | Biomarkers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |